Table 4 Independent prognostic factors among PTL patients by multivariable Cox regression analysis
Overall survival | Cancer-specific survival | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age at diagnosis | ||||||
< 66 vs. ≥66 | 4.611 | 3.75–5.67 | < 0.001 | 3.976 | 3.21–4.93 | < 0.001 |
Marital status | ||||||
Unmarried vs. Married | 0.661 | 0.56–0.78 | < 0.001 | 0.866 | 0.73–1.04 | 0.113 |
Years of diagnosis | ||||||
1998–2003 vs. 2004–2009 | 0.941 | 0.78–1.13 | 0.520 | 1.307 | 1.04–1.64 | 0.020 |
1998–2003 vs. 2010–2015 | 0.705 | 0.55–0.90 | 0.005 | 1.721 | 1.33–2.23 | < 0.001 |
Classification | ||||||
HL vs. Aggressive B cell NHL | 2.300 | 0.57–9.29 | 0.242 | 1.969 | 0.49–7.97 | 0.342 |
HL vs. Indolent B cell NHL | 1.112 | 0.27–4.56 | 0.883 | 1.190 | 0.29–4.89 | 0.809 |
HL vs. T cell NHL | 3.438 | 0.48–24.60 | 0.219 | 1.364 | 0.12–15.16 | 0.801 |
HL vs. NHL-NOS | 1.965 | 0.47–8.20 | 0.354 | 1.388 | 0.33–5.89 | 0.656 |
HL vs. Other/Unclassified | 2.667 | 0.63–11.39 | 0.185 | 2.047 | 0.47–8.93 | 0.340 |
Lymphoma Ann Arbor Stage | ||||||
Stage I vs. Stage II | 1.268 | 1.06–1.52 | 0.009 | 1.292 | 1.06–1.58 | 0.011 |
Stage I vs. Stage III | 0.996 | 0.62–1.59 | 0.988 | 1.068 | 0.66–1.74 | 0.790 |
Stage I vs. Stage IV | 1.421 | 1.09–1.85 | 0.008 | 1.481 | 1.11–1.98 | 0.008 |
Surgery | ||||||
No vs. Performed | 0.748 | 0.63–0.89 | 0.001 | 0.755 | 0.63–0.91 | 0.003 |
Chemotherapy | ||||||
No vs. Performed | 0.561 | 0.46–0.68 | < 0.001 | 0.539 | 0.44–0.67 | < 0.001 |
Radiation | ||||||
No vs. Performed | 0.737 | 0.62–0.87 | < 0.001 | 0.751 | 0.63–0.90 | 0.002 |